Company: CSCIF
Filing Date: 2025-04-09
Form Type: 20-F
Source: 0001641172-25-003456
Chunk: 187

Company: COSCIENS Biopharma Inc.
Filing Date: 2025-04-09
Form: 20-F
Item: Item 10
Chunk 187
---
 applicable to U.S. Holders. In addition, this discussion is limited to U.S. Holders holding Common Shares as capital assets. For purposes of this summary, “U.S. Holder” means a beneficial holder of Common Shares who or that for U.S. federal income tax purposes is:
 

●                                                                    an                                                                
                                                individual citizen or resident of the U.S.;                                            
---------------------------------------------------------------------------------------------------------------------------------------
●   a                                                                                                                                  
    corporation or other entity classified as a corporation for U.S. federal income tax purposes created or organized in or under the  
    laws of the U.S., any state thereof or the District of Columbia;                                                                   
●   an                                                                                                                                 
    estate, the income of which is subject to U.S. federal income taxation regardless of its source; or                                
●   a                                                                                                                                  
    trust, if (a) a court within the U.S. is able to exercise primary supervision over the administration of such trust and one or more
    “U.S. persons” (within the meaning of the Code) have the authority to control all substantial decisions of the trust,              
    or (b) a valid election is in effect to be treated as a U.S. person for U.S. federal income tax purposes.                          
 
If a partnership or other entity or arrangement classified as a partnership for U.S. federal income tax purposes holds Common Shares, the U.S. federal income tax treatment of a partner generally will depend on the status of the partner and the activities of the partnership. This summary does not address the tax consequences to any such partner. Such a partner should consult its own tax advisor as to the tax consequences of the partnership purchasing, owning and disposing of Common Shares.
 
U.S. HOLDERS SHOULD CONSULT THEIR OWN TAX ADVISORS WITH REGARD TO THE APPLICATION OF THE TAX CONSEQUENCES DESCRIBED BELOW TO THEIR PARTICULAR SITUATIONS AS WELL AS THE APPLICATION OF ANY STATE, LOCAL, FOREIGN OR OTHER TAX LAWS, INCLUDING GIFT AND ESTATE TAX LAWS.
 
For a summary of the U.S. federal income tax consequences to U.S. Holders of the receipt and exercise (or expiration) of the new warrants to be issued in connection with the Plan of Arrangement and the ownership and disposition of Common Shares received upon exercise of such warrants, please refer to the section entitled “U.S. Federal Income Tax Considerations for U.S. Holders” of our Registration Statement on Form F-1 filed with the SEC on February 15, 2024, which is incorporated herein by